Table 1 Characteristics of patients.
Characteristics | Number | Percentage (%) | Mean/median (SD or IQR)a |
|---|---|---|---|
Age (in years) | 31.3 (1.36) | ||
Sex | |||
Male | 359 | 67.9 | |
Female | 170 | 32.1 | |
Self-reported episodes of prior dengue (n-454) | |||
Yes | 27 | 5.9 | |
No | 427 | 94.1 | |
Dengue serotype of current infection (n-426) | |||
DENV1 | 50 | 11.7 | |
DENV2 | 260 | 61 | |
DENV3 | 109 | 25.6 | |
Serotype unassigned | 12 | 2.8 | |
Previous dengue infection (anti-dengue IgG + , n-507) | 342 | 67.5 | |
Median anti-dengue IgG titre of positive cases (RU/ml) | 179.6 (128.1–227.5) | ||
Previous Zika virus infection (anti-Zika IgG + , n-507) | 132 | 26 | |
Median anti-Zika IgG titre of positive cases (RU/ml) | 83.1 (47.9–120.8) | ||
Adverse outcomes of current dengue infection (n-446) | |||
Plasma Leakage | 260 | 58.3 | |
Compensated shock | 21 | 4.7 | |
Uncompensated shock | 11 | 2.1 | |
Severe dengue | 26 | 5.8 | |
